Improving the value of costly genetic reference laboratory testing with active utilization management.

CONTEXT Tests that are performed outside of the ordering institution, send-out tests, represent an area of risk to patients because of complexity associated with sending tests out. Risks related to send-out tests include increased number of handoffs, ordering the wrong or unnecessary test, specimen delays, data entry errors, preventable delays in reporting and acknowledging results, and excess financial liability. Many of the most expensive and most misunderstood tests are send-out genetic tests. OBJECTIVE To design and develop an active utilization management program to reduce the risk to patients and improve value of genetic send-out tests. DESIGN Send-out test requests that met defined criteria were reviewed by a rotating team of doctoral-level consultants and a genetic counselor in a pediatric tertiary care center. RESULTS Two hundred fifty-one cases were reviewed during an 8-month period. After review, nearly one-quarter of genetic test requests were modified in the downward direction, saving a total of 2% of the entire send-out bill and 19% of the test requests under management. Ultimately, these savings were passed on to patients. CONCLUSIONS Implementing an active utilization strategy for expensive send-out tests can be achieved with minimal technical resources and results in improved value of testing to patients.

[1]  Urmimala Sarkar,et al.  Frequency of failure to inform patients of clinically significant outpatient test results. , 2009, Archives of internal medicine.

[2]  Anand S Dighe,et al.  Utilization management in a large urban academic medical center: a 10-year experience. , 2011, American journal of clinical pathology.

[3]  Xavier Bossuyt,et al.  Laboratory medicine: challenges and opportunities. , 2007, Clinical chemistry.

[4]  A Robinson,et al.  Rationale for cost-effective laboratory medicine , 1994, Clinical Microbiology Reviews.

[5]  R. Arnaout,et al.  CallWall: tracking resident calls to improve clinical utilization of pathology laboratories. , 2011, Archives of pathology & laboratory medicine.

[6]  C. Naugler,et al.  An Intervention to Reduce Laboratory Utilization of Referred-Out Tests , 2012 .

[7]  Ana K Stankovic,et al.  Accuracy of send-out test ordering: a College of American Pathologists Q-Probes study of ordering accuracy in 97 clinical laboratories. , 2008, Archives of pathology & laboratory medicine.

[8]  Arthur L. Beaudet,et al.  Which way for genetic-test regulation? Leave test interpretation to specialists , 2010, Nature.

[9]  M H Liang,et al.  Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. , 1998, JAMA.

[10]  M. Astion,et al.  Utilization and diagnostic yield of neurogenetic testing at a tertiary care facility. , 2007, Clinical chemistry.

[11]  B. Bennett,et al.  Reference test review by pathology house staff: a cost-containment strategy for the clinical laboratory. , 2002, Clinical leadership & management review : the journal of CLMA.

[12]  Kevin B. Johnson,et al.  The Impact of Peer Management on Test-Ordering Behavior , 2004, Annals of Internal Medicine.

[13]  R. Sachdeva,et al.  Making the case to improve quality and reduce costs in pediatric health care. , 2009, Pediatric clinics of North America.

[14]  Gail Javitt,et al.  Which way for genetic-test regulation? Assign regulation appropriate to the level of risk , 2010, Nature.

[15]  D. Preciado,et al.  Improved Diagnostic Effectiveness with a Sequential Diagnostic Paradigm in Idiopathic Pediatric Sensorineural Hearing Loss , 2005, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.